Philips, Celsion focus on targeted cancer therapy
This article was originally published in Clinica
Executive Summary
Philips Healthcare and Celsion have entered a joint research agreement to explore the combined use of high-intensity focused ultrasound (HIFU) and heat-activated pharmaceuticals to provide a more targeted treatment for cancer.